Alignment Healthcare (NASDAQ:ALHC) & INVO Fertility (NASDAQ:IVF) Critical Comparison
by Scott Moore · The Cerbat GemAlignment Healthcare (NASDAQ:ALHC – Get Free Report) and INVO Fertility (NASDAQ:IVF – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.
Risk and Volatility
Alignment Healthcare has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500.
Profitability
This table compares Alignment Healthcare and INVO Fertility’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Alignment Healthcare | 0.89% | 20.02% | 3.46% |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
Analyst Ratings
This is a summary of current ratings for Alignment Healthcare and INVO Fertility, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Alignment Healthcare | 0 | 4 | 7 | 0 | 2.64 |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
Alignment Healthcare currently has a consensus price target of $23.60, indicating a potential upside of 87.15%. INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 1,963.77%. Given INVO Fertility’s higher possible upside, analysts clearly believe INVO Fertility is more favorable than Alignment Healthcare.
Valuation & Earnings
This table compares Alignment Healthcare and INVO Fertility”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Alignment Healthcare | $3.95 billion | 0.66 | -$720,000.00 | $0.19 | 66.37 |
| INVO Fertility | $6.84 million | 0.36 | -$25.13 million | ($33.83) | -0.03 |
Alignment Healthcare has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by company insiders. Comparatively, 0.4% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Alignment Healthcare beats INVO Fertility on 12 of the 15 factors compared between the two stocks.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.